Clinical Trial Update: Clopidogrel For the Prevention of New Onset Migraine Headache Following Transcatheter Closure of Atrial Septal Defects [Phase 4]

View source ↗

Summary

Phase 4 trial update on clopidogrel for preventing new onset migraine after transcatheter ASD closure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Laval University | Conditions: Migraine | Phase 4 | Status: COMPLETED